AI entity
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention ADMA Biologics, Inc., the most common co-covered peer. They are better corroborated than the beat average, carrying 4 original sources each against 2.7 for the same window.
Last mentioned: Jul 12, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention ADMA Biologics, Inc., the most common co-covered peer. They are better corroborated than the beat average, carrying 4 original sources each against 2.7 for the same window. The average consequence score is 7, matching the 7 beat baseline for this window. Embecta Corp. appears in 1 tracked AI story from July 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 28 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Embecta Corp.. Shared-story counts are live from our verified record — not editorial picks.
The AI sector’s poster child, Microsoft Copilot, is at the center of a securities fraud lawsuit for allegedly concealing functionality issues that hurt Azure growth and investor returns.
Embecta Corp. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
